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Introduction
!
Crohn’s disease and ulcerative colitis are lifelong
diseases observed predominantly in the devel-
oped countries of the world. Within Europe there
is a distinct north–south gradient, but the inci-
dence appears to have increased in southern
countries in recent years [1]. Both diseases are
marked by frequent relapses and patients often
undergo repeated investigations. Whereas ulcera-
tive colitis is a chronic inflammatory condition
causing diffuse and continuous mucosal inflam-
mation of the colon, Crohn’s disease is a heteroge-
neous entity comprised of several different phe-
notypes, but can affect the entire gastrointestinal
tract. A change in diagnosis from Crohn’s disease
to ulcerative colitis during the first year of illness
occurs in about 10%–15% of cases. Inflammatory
bowel disease (IBD) restricted to the colon that
cannot be characterized as either ulcerative colitis
or Crohn’s disease is termed IBD-unclassified
(IBDU). By common consent the term „IBDU“ has
replaced the inappropriate term „indeterminate
colitis“ [2].
The advent of capsule and both single- and dou-
ble-balloon-assisted enteroscopy is revolutioniz-
ing small-bowel imaging and has major implica-
tions for diagnosis, classification, therapeutic de-
cision making, and outcomes in the management
of IBD. Until a decade ago, mucosal visualization
of the small bowel was limited to the reach of the
push enteroscope (excluding invasive and expen-
sive intraoperative enteroscopy). The advent of
small-bowel capsule endoscopy (SBCE) allowed
for the first time direct visualisation of the entire
small bowel, albeit without the ability for tissue
sampling. As both ulcerative colitis and Crohn’s
disease are diagnosed on the basis of the combi-
nation of endoscopic, histological, radiological,
and biochemical investigations [3,4] the clinical
application of SBCE in the management of all IBD
is unclear. This is important, because up to 13% of
Crohn’s disease and ulcerative colitis are lifelong
diseases seen predominantly in the developed
countries of the world. Whereas ulcerative colitis
is a chronic inflammatory condition causing dif-
fuse and continuous mucosal inflammation of
the colon, Crohn’s disease is a heterogeneous en-
tity comprised of several different phenotypes,
but can affect the entire gastrointestinal tract. A
change in diagnosis from Crohn’s disease to ul-
cerative colitis during the first year of illness oc-
curs in about 10%–15% of cases. Inflammatory
bowel disease (IBD) restricted to the colon that
cannot be characterized as either ulcerative colitis
or Crohn’s disease is termed IBD-unclassified
(IBDU). The advent of capsule and both single-
and double-balloon-assisted enteroscopy is revo-
lutionizing small-bowel imaging and has major
implications for diagnosis, classification, thera-
peutic decisionmaking and outcomes in the man-
agement of IBD. The role of these investigations in
the diagnosis and management of IBD, however,
is unclear.This document sets out the current
Consensus reached by a group of international ex-
perts in the fields of endoscopy and IBD at a meet-
ing held in Brussels, 12–13th December 2008, or-
ganised jointly by the European Crohn’s and Coli-
tis Organisation (ECCO) and the Organisation
Mondiale d’Endoscopie Digestive (OMED). The
Consensus is grouped into seven sections: defini-
tions and diagnosis; suspected Crohn’s disease;
established Crohn’s disease; IBDU; ulcerative coli-
tis (including ileal pouch–anal anastomosis
[IPAA]); paediatric practice; and complications
and unresolved questions.Consensus guideline
statements are followed by comments on the evi-
dence and opinion. Statements are intended to be
read in context with qualifying comments and
not read in isolation.
* Contributed equally
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normal, asymptomatic people are found to have lesions of un-
known clinical significance in the small bowel at SBCE. It has
been difficult to correlate the findings at SBCE with clinical pre-
sentation in the absence of definitive histopathology. More re-
cently, advanced endoscopic techniques of balloon-assisted and
spiral enteroscopy have allowed direct tissue sampling for histo-
pathology and therapeutic procedures in the small bowel. The
role of these investigations in the diagnosis and management of
IBD, however, is unclear. In the absence of national and interna-
tional recommendations, we believed that a formal Consensus
conference on this topic would help to standardize and optimize
patient care.
This Consensus aims to provide a worldwide perspective on the
use of small-bowel endoscopy in the management of IBD. Since
the development of guidelines is an expensive and time-consum-
ing process, it may help to avoid duplication of effort in the fu-
ture. This document sets out the current Consensus reached by a
group of international experts in the fields of endoscopy and IBD
at a meeting held in Brussels, 12–13th December 2008, orga-
nised jointly by the European Crohn’s and Colitis Organisation
(ECCO) and the Organisation Mondiale d’Endoscopie Digestive
(OMED). The Consensus is grouped into seven sections: defini-
tions and diagnosis; suspected Crohn’s disease; established
Crohn’s disease; IBDU; ulcerative colitis (including ileal pouch–
anal anastomosis [IPAA]); paediatric practice; and complications
and unresolved questions.
The strategy to reach the Consensus involved five steps:
Relevant questions on each of the seven separate topics were de-
vised by the Steering Committee and sent to seven working
groups of endoscopy and IBD specialists, who were selected for
their interest in the field. Each group had a leader and two or
more contributingmembers. The leader was encouraged to invite
a young gastroenterologist (age < 35 years!) to join the group.
1. The questions were focused on current practice and areas of
controversy in the task force topic, and sent to all participants
in the Consensus conference. Working groups were asked to
answer the questions based on their experience as well as
evidence from the literature (Delphi procedure) [5].
2. The working parties performed a systematic literature search
of their topic with the appropriate key words using Medline/
Pubmed/EMBASE and the Cochrane database, as well as their
own files. The evidence level (EL) was graded (●" Table 1) ac-
cording to the system of the Oxford Centre for Evidence-Based
Medicine [6].
3. Working groups wrote provisional guideline statements on
their topic, based on answers to the questionnaire as well as
the literature search, and these were circulated among the
participants.
4. The working parties of 40 participants then met in Brussels
12–13th December 2008 to agree on the final version of each
guideline statement. Statements were revised until a consen-
sus was reached. Consensus was defined as agreement by
> 80% of participants, termed a Consensus Statement, and
numbered for convenience in the document. Each recom-
mendation was graded (RG) according to the system of the
Oxford Centre for Evidence-Based Medicine [6], based on the
level of evidence (●" Table 1).
5. The members of the working party wrote the final document
on their topic, and these are presented here. Consensus
guideline statements are followed by comments on the evi-
dence and opinion. The statements are intended to be read in
context with the qualifying comments and not read in isola-
Levels of evidence Table 1 Levels of evidence
(EL) and grades of recommen-
dation (RG), adapted from the
criteria of the Oxford Centre for
Evidence-Based Medicine [6].
Level Individual study Technique
1a Systematic review with homogeneity of level 1
diagnostic studies
Systematic review with homogeneity of random-
ized controlled trials (RCTs)
1b Validating cohort study with good reference
standards
Individual RCT (with narrow confidence interval)
1c Specificity is so high that a positive result rules
in the diagnosis („SpPin“) or sensitivity is so high
that a negative result rules out the diagnosis
(„SnNout“)
All or none
2a Systematic review with homogeneity of level > 2
diagnostic studies
Systematic review (with homogeneity ) of cohort
studies
2b Exploratory cohort study with good reference
standards
Individual cohort study (including low quality
RCT; e. g., < 80% follow-up)
2c „Outcomes“ Research; Ecological studies
3a Systematic review with homogeneity of 3b and
better studies
Systematic review with homogeneity of case–
control studies
3b Nonconsecutive study; or without consistently
applied reference standards
Individual case-control study
4 Case–control study, poor or nonindependent
reference standard
Case series (and poor quality cohort and case–
control studies )
5 Expert opinion without explicit critical appraisal,
or based on physiology, bench research or „first
principles“
Expert opinion without explicit critical appraisal,
or based on physiology, bench research or „first
principles“
Grades of recommendation
A Consistent level 1 studies
B Consistent level 2 or 3 studies or extrapolations from level 1 studies
C Level 4 studies or extrapolations from level 2 or 3 studies
D Level 5 evidence or troublingly inconsistent or inconclusive studies of any level
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tion. The final text was edited for consistency of style by
A. Ignjatovic and A. Bourreille before being circulated and ap-
proved by the participants. In some areas the level of evidence
was generally low, reflecting the paucity of randomized con-
trolled trials. Consequently expert opinion was included
where appropriate.
SECTION 1
Procedural definitions and description
!
The Consensus group agreed on definitions, some of which are
recognized to be arbitary, and descriptions of the commonly
used terminology. These should provide standardization within
the field and allow for direct comparisons between research
groups.
1.1 Small-bowel endoscopy
‘Small-bowel endoscopy’ is defined as any endoluminal examina-
tion of the small bowel, including capsule endoscopy, push en-
teroscopy and balloon- or other device-assisted endoscopy.
1.2 Small-bowel capsule endoscopy
Small-bowel capsule endoscopy (SBCE) is a method of endolum-
inal examination of the small bowel using a wireless capsule-
shaped tool which is usually swallowed and then propelled
through the gastrointestinal tract by gut motility. Synonyms in-
clude: capsule enteroscopy, wireless capsule enteroscopy, video
capsule endoscopy.
SBCE utilizes a miniaturized complementary metal oxide semi-
conductor (CMOS) or charge-coupled device (CCD)-based cam-
era, embedded in a 11mm ×26mm capsule-shaped instrument.
The capsule also contains batteries, light-emitting diode (LED)-
based illumination, and a transmitter for wireless transfer of ima-
ges to an external antenna and receiving storage unit. During the
battery life of the capsule, images are recorded, usually from the
upper gastrointestinal tract and small bowel. The images are re-
formatted into a continuous video file that can be reviewed on a
normal computer using specially adapted software. After 8–10
hours, the antenna and storage unit are removed and the images
transferred to a computer for analysis and review by an experi-
enced capsule endoscopist.
The main advantages of the SBCE method are the ability to visua-
lize all of the small bowel with minimal discomfort for the pa-
tient. The procedure also requires less physician training than ad-
vanced endoscopic techniques.
The main disadvantages are the inability to manoeuvre the cap-
sule, the lack of therapeutic capabilities, and the relative contra-
indication of possible strictures, because of the risk of impaction
[7,8]. Furthermore, although most images are excellent, they are
still not comparable to the view achieved at conventional endos-
copy with gas insufflation.
1.3 Push enteroscopy
Push enteroscopy is an endoluminal examination of the proximal
jejunum using a long, flexible endoscope.
Until the last decade, the complete assessment of the small intes-
tine eluded gastroenterologists. Push enteroscopy allowed exam-
ination of the proximal small bowel. The tipp of a long endoscope
(colonoscope, paediatric colonoscope, or enteroscope) was
passed beyond the ligament of Treitz, sometimes through an
overtube to avoid intragastric loops. Push enteroscopy did not
permit visualization of the distal portions of the small intestine
but allowed tissue sampling, polypectomy, and treatment of
bleeding lesions [9]. In recent years, balloon-assisted endoscopic
techniques have largely replaced push enteroscopy in examina-
tion of the small bowel.
1.4 Double-balloon enteroscopy
Double-balloon enteroscopy (DBE) is defined as endoluminal ex-
amination of the small bowel using a double-balloon endoscope.
DBE, first described by Yamamoto and colleagues in 2001 [10], al-
lows deep (even complete) intubation of the small bowel by
pleating the bowel onto a long, flexible endoscope fitted with an
overtube. The endoscope and the accompanying overtube have
balloons at their distal end. By intermittent inflation and defla-
tion of these two balloons, combined with instrument insertion
and retraction, large portions of the small bowel can be visualiz-
ed directly. Oral and anal routes, alone or in combination, are
used to achieve complete small-bowel examination. The proce-
dure is performed with conscious sedation or general anaesthe-
sia. A range of accessories has been developed to allow tissue
sampling and therapeutic procedures. DBE is a complex examina-
tion and should only be carried out by trained and experienced
endoscopists. The standard method requires two individuals, an
operator who handles the enterosocope and an assistant who
handles the overtube.
1.5 Single-balloon enteroscopy
Single-balloon enteroscopy (SBE) is defined as endoluminal ex-
amination of the small bowel using a single-balloon endoscope.
Manufacturers have developed their own versions of instru-
ments able to achieve complete examination of the small bowel
(such as the single-balloon enteroscope) using principles similar
to DBE. The tipp of a single-balloon enteroscope, which does not
have a distal end balloon [11], is fixed by tipp angulation. An
overtube with an integrated channel for a balloon catheter has
also been developed. DBE has been used in the majority of stud-
ies published to date. There are no studies comparing different
balloon-assisted enteroscopes.
1.6 Balloon-assisted enteroscopy
Balloon-assisted enteroscopy (BAE) is a generic term for endo-
luminal examination of the small bowel by any endoscopic tech-
nique that includes balloon-assisted progression.
1.7 Device-assisted enteroscopy
Device-assisted enteroscopy (DAE) is a generic term for endo-
luminal examination of the small bowel by any endoscopic tech-
nique that includes assisted progression (e.g. by a balloon, over-
tube, or other stiffening device).
1.8 Intraoperative enteroscopy
Intraoperative enteroscopy (IOE) is defined as an endoluminal
examination of the small bowel during abdominal surgery with
manual external assistance for endoscope progression.
By definition, IOE is an exploration of the small intestine with an
endoscope (gastroscope, colonoscope, pediatric colonoscope, or
enteroscope) during a surgical procedure. The endoscope can be
introduced either orally or via an enterotomy. The progression of
the endoscope through the intestine is facilitated by the manual
assistance of the surgeon. Like SBCE, IOE detects lesions inacces-
sible to conventional endoscopy [12–14]. Before surgery, these
lesions are not detected in more than half of the patients. No
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study has compared the performance of IOE with other endo-
scopic techniques in the detection of small-bowel lesions in
Crohn’s disease patients. Indications for IOE are limited by the in-
vasiveness of the procedure. Furthermore, observation of small-
bowel lesions at enteroscopy but without removal at ileocolonic
resection does not alter the risk of postoperative endoscopic re-
currence [14].
1.9 Spiral enteroscopy
Spiral enteroscopy is a recently developed technique. An entero-
scope, introduced orally, is passed through a single-use overtube,
which has helical spirals at its distal end and rotates independ-
ently from the enteroscope. The enteroscope can be locked in
the overtube allowing the option of spiral enteroscopy, or un-
locked and advanced through the overtube [15,16]. The feasibil-
ity of the technique has not been demonstrated in patients with
IBD, and no study has compared spiral enteroscopy with other
endoscopic techniques.
SECTION 2
Suspected Crohnʼs disease
!
2.1 Introduction
There is no single, gold standard diagnostic test for Crohn’s dis-
ease. The diagnosis is based on a constellation of findings, includ-
ing the history and physical examination, endoscopic and radio-
logical features, and laboratory and pathology findings [4]. Stud-
ies have suggested that up to 30% of patients diagnosed with
Crohn’s disease will have only small-bowel involvement [17,18].
Until recently, the diagnosis of small-bowel Crohn’s disease was
made on the basis of small-bowel radiology and ileocolonoscopy,
occasionally augmented by push enteroscopy or IOE. Options are
still limited for histopathological confirmation of the diagnosis of
small-bowel Crohn’s disease, especially when attempting to con-
firm a new diagnosis.
The new endoscopic techniques improve the clinician’s ability to
identify subtle lesions that may be associated with an initial pre-
sentation of Crohn’s disease [19]. In parallel with these endo-
scopic advances, the resolution of radiographic studies of the
small bowel has markedly improved. Clinicians have access to
more sensitive radiographic studies to secure a diagnosis of
Crohn’s disease. Small-bowel follow-through (SBFT) and entero-
clysis, until now considered the gold standards for radiographic
assessment of the small bowel, are being replaced by computer-
ized tomography (CT)- and magnetic resonance (MR)-based en-
terography studies that may be more accurate for diagnosing
small-bowel Crohn’s disease.
The place that these new procedures and technologies will occu-
py in the diagnostic algorithm of suspected Crohn’s disease re-
mains to be fully determined. Early studies have shown them to
be complementary to upper endoscopy and ileocolonoscopy, as
well as complementary to one another.
2.2 SBCE in patients with suspected Crohn’s disease
2.2.1 Indications for SBCE in patients with suspected
Crohn’s disease
Diagnosis of terminal ileal Crohn’s disease can be usually made at
ileocolonoscopy, which should be performed before SBCE is con-
templated. If the ileocaecal valve proves impossible to intubate,
SBCE may be considered unless there is evidence of strictures:
SBCE findings consistent with Crohn’s disease were reported in
2/4 patients with an incomplete colonoscopy [20]. A study exam-
ining the sensitivity and specificity of different combinations of
ileocolonoscopy, CT enterography (CTE), SBCE, and SBFT found
that ileocolonoscopy with either CTE or SBFTwas more accurate
than SBCE with CTE, SBFT, or ileocolonoscopy, because of the
lower specificity of SBCE [21]. These findings suggest that SBCE
should be reserved for cases in which ileocolonoscopy plus
small-bowel radiography is not diagnostic, but the suspicion of
Crohn’s disease remains high. SBCE offers the advantage of visua-
lizing the entire small bowel, although the caecum is not reached
in 8%–40% of SBCE studies [19–26].
Suboptimal bowel preparation can limit image quality in the dis-
tal small bowel. Preparations for a SBCE study usually include 8–
12 hours’ fasting and some method of bowel cleansing (e.g. in-
gestion of 2 L of polyethylene glycol [PEG] solution. A meta-anal-
ysis, yet to be reported in full, has found that the diagnostic yield
of SBCE and the quality of small-bowel visualization were signifi-
cantly higher in patients who had a purgative bowel preparation
(n = 263) compared with those given a liquid diet alone (n = 213),
with a pooled odds ratio [OR] of 1.81 (95% confidence interval
[CI] 1.25–2.62, P = 0.002) and OR of 2.11 (95%CI 1.25–3.57),
respectively [27]. However, the number of patients with suspect-
ed or established Crohn’s disease included in the different studies
was low and it has not been shown that cleanliness of the small
bowel affects the diagnostic yield in the subset of patients with
suspected Crohn’s disease. Prokinetics or simethicone have been
used to improve the results, but are not generally recommended
[28].
Statement 2A
" Ileocolonoscopy must be performed prior to SBCE for the
diagnosis of Crohn’s disease [EL4, RG C]
" Small-bowel cross-sectional imaging should generally
precede SBCE. The choice of radiographic imaging depends
on local availability and expertise [EL5, RG D]
" There is no available evidence to support a particular bowel
preparation for SBCE in the subset of patients with sus-
pected Crohn’s disease [EL5 RG D]
Statement 2B
" SBCE is able to identify mucosal lesions compatible with
Crohn’s disease in some patients in whom conventional
endoscopic and small-bowel radiographic imaging modal-
ities have been nondiagnostic [EL4, RG C]
" As with other imaging modalities, a diagnosis of Crohn’s
disease should not be based on the appearances at capsule
endoscopy alone [EL5, RG D]
" A normal capsule endoscopy has a high negative predictive
value for active small-bowel Crohn’s disease [EL4, RG D]
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While most studies use similar definitions for a diagnosis of
Crohn’s disease based on SBCE (●" Table 2), this definition is arbi-
trary and has not been prospectively validated. This may increase
the number of false-positive findings. No studies, to date, have
defined precisely findings on SBCE that constitute a diagnosis of
Crohn’s disease. Lesions detected by SBCE are nonspecific and
cannot be distinguished from lesions seen in patients treated by
nonsteroidal anti-inflammatory drugs (NSAIDs). Discrimination
of ulcerative lesions in the small bowel between those related to
Crohn’s disease, NSAIDs, or other aetiologies seems impossible on
the basis of endoscopic images (●" Fig. 1). Some small-bowel le-
sions may be found in up to 75% of NSAID users, even after 2
weeks’ ingestion of such drugs [29,30]. Selective cyclooxygen-
ase-2 (COX2) inhibitors are associated with small-bowel lesions
less frequently than conventional NSAIDs [31]. Taking a thorough
clinical history, including recent NSAID ingestion, is therefore es-
sential to improve the predictive value of findings at SBCE (see
also section 7.4.2).
It is important to understand that many lesions described in
studies of suspected Crohn’s disease are not specific and this
could explain the variability of the ‘diagnostic yield’ of SBCE. The
‘diagnostic yield’ is the number of examinations with abnormal
findings divided by the total number of examinations, and should
not be confused with either ‘sensitivity’ (the number of true-po-
sitive examinations divided by the total of true-positive and
false-negative examinations), or ‘specificity’ (the number of
true-negative examinations divided by the total of true-nega-
tives and false-positives). A test with a high diagnostic yield
does not necessarily mean the test has high sensitivity or speci-
ficity. SBCE may reveal small alterations such as lymphangiecta-
sia, villous denudation, or nodular lymphoid hyperplasia. These
nonspecific lesions have all been considered to be early manifes-
tations of Crohn’s disease in some series, but not in others (●" Ta-
ble 2). There are no prospectively validated diagnostic criteria.
The presence of more than three ulcerations, in the absence of
NSAIDs ingestion, constitutes the most commonly used diagnos-
tic criterion for Crohn’s disease, proposed by Mow et al. [19].
Existing endoscopic scores and indices of severity for Crohn’s dis-
ease have only been validated for ileocolonoscopy and include
both the Crohn’s Disease Endoscopic Index of Severity (CDEIS)
[32] and the Simple Endoscopic Score for Crohn’s Disease (SES-
Crohn’s disease ) [33]. The Rutgeerts’ score is applied to the post-
operative neoterminal ileum and can help predict the risk of clin-
ical recurrence [34]. Recently developed capsule endoscopy as-
Fig. 1 Subtle lesions as seen at small-bowel capsule endoscopy (SBCE).
Table 2 Criteria used to diagnose Crohn’s disease on small-bowel capsule endoscopy (SBCE).
Patients
(suspected Crohn’s), n
Comparator Diagnostic criteria (SBCE) Findings
Costamagna et al. 2002 [37] 20 (1) SBFT Medically significant Ulcers
Eliakim et al. 2004 [67] 25 (25) SBFT/CT Medically significant Ulcers, erosions, erythema,
aphthae, nodular lymphoid
hyperplasia
Dubcenco et al. 2005 [23] 44 (11) SBFT ≥ 3 ulcerations Erythema, oedema, loss
of villi, stricture, mucosal
fissure, fistula scarring
Chong et al. 2005 [24] 43 (21) SBFT/push enteroscopy Medically significant Erosions, ulcers
Hara et al. 2006 [20] 17 (8) SBFT/CT Consistent with Crohn’s
disease
Erosion, ulcer, stricture
Golder et al. 2006 [25] 36 (2) MR enteroclysis > 1 aphthoid ulcer Not described
Solem et al. 2008 [21] 41 (?) SBFT/CT Consistent with Crohn’s
disease
Unknown
SBFT, small-bowel follow-through; CT, computed tomography; MR, magnetic resonance.
Statement 2C
" There are no validated diagnostic criteria for SBCE for the
diagnosis of Crohn’s disease
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sessment scores are based on the degree of villous oedema, ul-
ceration and stenosis [35], or degree of inflammation, extent of
disease and strictures [36], but need to be prospectively validat-
ed. Scores for diagnosis and for assessing the activity or severity
of Crohn’s disease by SBCE or DAE should correlate with clinical
disease activity and influence therapeutic measures and out-
come.
2.2.2 How does SBCE compare with other imaging
modalities in patients with suspected Crohn’s disease?
2.2.2.1 SBCE compared with SBFT/enteroclysis
At least seven studies, which included patients with suspected
Crohn’s disease and largely excluded those with a suspected or
known small-bowel stricture, have compared SBCE with SBFT
[20,21,23,24,37–39]. Most of the studies have shown that the
diagnostic yield of SBCE is superior to that of SBFT, but these dif-
ferences reached statistical significance in only one study [39].
Two studies used a consensus gold standard for final diagnosis,
and both reported a trend towards improved sensitivity with
SBCE [21,23]. However, the results for patients with suspected
Crohn’s disease were not separated from those with known
Crohn’s disease. One meta-analysis reported a pooled OR for
SBCE of 13.0 (95%CI 3.2–16.3; P < 0.0001) compared with SBFT
in detecting small-bowel abnormalities in patients with known
or suspected Crohn’s disease [40]. However, as mentioned pre-
viously, one must proceed very cautiously when examining diag-
nostic yield without taking into account specificity.
Other studies have compared SBCE with enteroclysis, but small
sample sizes have limited the ability to show a significant advan-
tage [24,41,42]. In one meta-analysis, the pooled OR for detect-
ing abnormalities in patients with known or suspected Crohn’s
disease was 5.4 (95%CI 3.0–9.9) for SBCE compared with entero-
clysis [40], but this again needs to be interpreted cautiouslywith-
out information about the specificity of the procedure.
Another meta-analysis evaluated 97 patients with suspected
Crohn’s disease, but could not detect a significant difference in di-
agnostic yield between SBCE and SBFT/enteroclysis [43]. SBCE
was found to have an increased diagnostic yield of 30% using a
fixed-effect model, which decreased to a nonsignificant in-
creased yield of 24% using a random-effect model (P = 0.09).
2.2.2.2 SBCE compared with magnetic resonance (MR)
enterography
Another study of just 25 patients with suspected Crohn’s disease
used a composite gold standard for diagnosis, and compared
SBCE with MR enteroclysis [44]. SBCE had a sensitivity of 92%
and specificity of 100%, compared with a sensitivity of 77% and
specificity of 80% for magnetic resonance imaging (MRI). In two
patients, SBCE was the only confirmatory test, after a nondiag-
nostic MRI and enteroclysis. A studywhich included only two pa-
tients with suspected Crohn’s disease compared SBCE with MR
enterography and found no difference [25].
2.2.2.3 SBCE compared with computed tomographic
enterography (CTE)/CT enteroclysis
One group has compared SBCE with CT enteroclysis in the evalu-
ation of suspected Crohn’s disease [45]. Among 22 patients with
suspected small-bowel disease, eight had suspected Crohn’s dis-
ease and no difference was found between the modalities
(P = 0.12), but the study was clearly underpowered and the sub-
set of patients with suspected Crohn’s disease was not reported
separately. Three studies have compared SBCE with CTE
[20,21,39]. Two studies found no difference in diagnostic yield
or sensitivity, although one reported a higher specificity for CTE
[21]. In the third study of 35 individuals with suspected Crohn’s
disease, SBCE had an incremental diagnostic yield of 57% com-
pared with CTE, which was statistically significant [39]. A meta-
analysis of 43 patients with suspected Crohn’s disease found an
incremental diagnostic yield of 40% with SBCE compared with
CT enteroclysis and CTE, but this difference did not reach statisti-
cal significance (P = 0.07) [43].
2.3 Device-assisted endoscopy (DAE) in patients
with suspected Crohn’s disease
2.3.1 Indications for DAE in patients with suspected
Crohn’s disease
Two small studies have reported a 30%–48% diagnostic yield of
double-balloon endoscopy (DBE) when evaluating patients with
suspected Crohn’s disease [46,47]. In a study of single-balloon
endoscopy (SBE) in 41 individuals, of whom 17 had suspected
Crohn’s disease [11], 16/41 had Crohn’s disease as their final di-
agnosis, although the results were not reported by indication.
The advantages of balloon-assisted endoscopy (BAE) compared
with SBCE include the evaluation of atypical lesions, the ability
to obtain biopsies for histopathology, and the potential for thera-
peutic intervention (e.g. dilation) [48,49].
Overall, BAE is safe in the assessment of suspected Crohn’s dis-
ease, with few reports of complications [11,47,49,50] (see Sec-
tion 7).
Statement 2E
" SBCE may be superior to MR enterography for detection
of mucosal lesions consistent with Crohn’s disease
[EL3a, RG C]
Statement 2D
" SBCE may be better than small-bowel follow-through or
enteroclysis at identifying small-bowel mucosal lesions
consistent with Crohn’s disease [EL3a, RG C]
Statement 2F
" SBCE may be superior to CTE or CT enteroclysis for detec-
tion of mucosal lesions consistent with Crohn’s disease
[EL3a, RG C]
Statement 2G
" DAE can be used to diagnose Crohn’s disease, because his-
tological corroboration is available [EL5, RG D]
" There are not enough data to recommend DAE, unless con-
ventional studies including ileocolonoscopy and radio-
graphic imaging have been inconclusive and histological
diagnosis would alter disease management
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2.3.2 How does BAE compare with other imaging
modalities in patients with suspected Crohn’s disease?
2.3.2.1 BAE compared with SBCE
Two abstracts report a comparison between DBE and SBCE in sus-
pected Crohn’s disease. In a preliminary study, 44 patients with
suspected small-bowel Crohn’s disease who had a prior SBCE un-
derwent DBE [51]. A new diagnosis of Crohn’s disease was made
in 14% after DBE, and Crohn’s disease was excluded in 9%, but the
analysis was not performed separately for established and sus-
pected Crohn’s disease. DBE led to treatment changes in 73% of
subjects. These are all clinically relevant end points. Another pre-
liminary study included 12 patients with suspected Crohn’s dis-
ease among 129 undergoing DBE; 88 patients had undergone a
prior SBCE [52]. Of SBCE findings, 65% were confirmed by DBE
and 10% of DBE findings were missed by SBCE.
2.3.2.2 BAE compared with SBFT
One study only published as an abstract compared DBEwith SBFT
in 18 patients with suspected small-bowel disease, but not speci-
fically with suspected Crohn’s disease [53]. Agreement between
DBE and SBFT was reported in 60%, 60% and 50% of patients
with gastrointestinal bleeding, abdominal pain, and diarrhoea,
respectively.
2.3.2.3 BAE compared with MR enterography
A study on 10 patients with suspected Crohn’s disease proximal
to the terminal ileum compared DBE with MR enteroclysis [49].
All DBE examinations used the oral route, with complete small-
bowel examination achieved in only one patient. MR enteroclysis
and DBE agreed in 21 bowel segments (75%) andwere discordant
in 7 (25%). Five patients had abnormal findings detected by both
modalities. In all DBE cases, Crohn’s disease was verified histolo-
gically. Although the value of MR enteroclysis appeared limited in
patients with subtle or superficial mucosal lesions, incomplete
examination by DBE was a major limiting factor.
2.3.3 Specific considerations or investigations
recommended prior to SBE/DBE in patients with
suspected Crohn’s disease
DAE should not be the first-line procedure in the evaluation of
suspected small-bowel Crohn’s disease. SBCE can be complemen-
tary to BAE, since findings may help direct the most effective
route of intubation (oral versus anal), in order to obtain a histo-
pathological diagnosis, or therapeutic intervention [47,48,51].
DAE may be preferable to SBCE if there is a clinical suspicion of
obstruction, because it may allow therapeutic intervention and
be safer, simply by avoiding capsule retention [46]. Disadvanta-
ges associated with DAE are the invasiveness of the examination,
the need for sedation, limited availability of the procedure (spe-
cialized centres), difficulty in examining the entire small bowel,
and the time and expense required for the procedure [11,47,50].
SECTION 3
Established Crohnʼs disease
!
3.1 Introduction
Endoscopy plays an important role in the evaluation and moni-
toring of established Crohn’s disease [4]. Ileocolonoscopy and up-
per gastrointestinal endoscopy havewell-established roles for as-
sessment of disease activity and therapeutic intervention; the
small bowel beyond the duodenum and proximal to the (neo)
terminal ileum is inaccessible to conventional endoscopy. Prior
to the advent of current techniques of DAE, push enteroscopy
was a practical alternative to IOE, which was too invasive for all
but the most unusual circumstances. Push enteroscopy, however,
could effectively only examine 50 to 150 cm beyond the ligament
of Treitz [54–56]. The roles for SBCE and BAE in the assessment
and treatment of established Crohn’s disease [11,57–63] still
need to be defined.
3.2 SBCE in patients with established Crohn’s disease
3.2.1 Indications for SBCE in patients with established
Crohn’s disease
Most patients with Crohn’s disease have lesions located in the
(neo)terminal ileum, accessible by ileocolonoscopy. These pa-
tients can usually be managed without the need for additional
small-bowel endoscopy. However those patients with unex-
plained symptoms and inconclusive radiographic imaging and/
or ileocolonoscopy, may well have subtle small-bowel lesions.
SBCE allows these superficial lesions to be detected, which may
affect the therapeutic management. It should be remembered
that in contrast to SBCE, imaging by CTE or MR enterography
can assess transmural damage and extraintestinal features or
complications and may also give an indication of disease activity.
The potential for capsule retention in established Crohn’s disease
should also be considered (see Section 7) [64–66].
3.2.2 How does SBCE compare with other imaging
modalities in patients with established Crohn’s disease?
The role of SBCE in suspected Crohn’s disease is covered in Sec-
tion 2 [20–22,26,42,43,67,68]. In patients with established
Crohn’s disease, one meta-analysis has reported a 78% diagnostic
yield for SBCE compared with 32% for SBFT (P < 0.001). Further-
Statement 3B
" For patients with established Crohn’s disease, SBCE is
better at identifying small-bowel mucosal lesions than
barium and may be better than CT or MR enterography or
enteroclysis [EL3a, RG C], but the clinical significance of
this potential difference remains to be defined
Statement 3A
" The role of SBCE in patients with established Crohn’s dis-
ease should focus on patients with unexplained symptoms
when other investigations are inconclusive, if this will alter
management [EL5, RG D]
" Radiographic imaging takes precedence over SBCE because
it can potentially identify obstructive strictures, extralum-
inal disease, the transmural nature, or anatomical distri-
bution of disease
Statement 2H
" The decision onwhether SBCE or DAE should be performed
first depends on the nature and location of the small-bowel
lesion, as well as local availability and expertise
" For suspected Crohn’s disease where other investigations
are inconclusive, SBCE is generally appropriate
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more, SBCE had a 68% diagnostic yield for active Crohn’s disease,
compared with 38% for CT enterography/enteroclysis (P < 0.001)
[43].
One study compared SBCE with MR enterography in 27 patients
with established Crohn’s disease. Diagnostic yields for SBCE and
MR enterography were 93% and 79%, respectively [44], but it is
not clear how this correlated with either symptoms or the out-
come of therapeutic intervention. This is important, because
knowing that a segment of small bowel looks abnormal in 93%
of patients with established Crohn’s disease does not provide
much useful information unless it affects a patient’s manage-
ment.
Another study evaluated 19 patients with proven Crohn’s disease
using MR enteroclysis and SBCE; overall MR enteroclysis and
SBCE showed good correlation in the detection and locating of in-
flammatory bowel disease. MR enteroclysis underestimated de-
gree of pathology in 14% of segments and revealed more severe
pathology in 12% segments; SBCE identified subtle (n = 7) or se-
vere (n = 2) mucosal pathology while MR enteroclysis was nor-
mal. SBCE entirely missed severe inflammatory mural changes
identified byMR enteroclysis in 1/52 (2%) segments. Bothmodal-
ities can be complementary [69].
A notable limitation of SBCE is that it evaluates only nonstrictur-
ing Crohn’s disease and cannot usefully assess transmural or ex-
traintestinal disease.
Endoscopic recurrence in the neoterminal ileum has been report-
ed in 73%–93% of patients at 1 year after ileocolonic resection
[34,70]. The severity of endoscopic lesions is associated with the
risk of clinical relapse.
Two studies have investigated SBCE for detecting recurrence in
patients with Crohn’s disease after surgery. In one study, recur-
rence defined by a Rutgeerts’ score ≥i1 (see Section 2.2.1) occured
in 21 patients (68%) and was detected by ileocolonoscopy in 19
patients. Sensitivity of ileocolonocopy was 90% and specificity
100%, and the sensitivity of SBCE was 62%–76% and specificity
100%. The severity of lesions as assessed by both methods cor-
related significantly (P < 0.05) [71].
In a second prospective study of 24 patients with Crohn’s disease,
recurrence (Rutgeerts’ score ≥i2) was visualized by ileocolono-
scopy in 25% and SBCE in 62%. SBCE detected proximal involve-
ment in 13 patients [72].
SBCE has a potential role in the assessment of mucosal healing
after drug therapy [73].
3.3 DAE in patients with established Crohn’s disease
3.3.1 Indications for DAE in patients with established
Crohn’s disease
DAE is indicated in established Crohn’s diseasewhen direct visua-
lization of the small intestine beyond the reach of ileocolonosco-
py is necessary, in order to exclude an alternative diagnosis (in-
cluding tuberculosis, lymphoma, or carcinoma) [11,59,63,74], or
undertake a therapeutic procedure including dilation of small-
bowel strictures, or removal of foreign bodies such as a capsule
or bezoar [60,75–80]. In the rare instanceswhere Crohn’s disease
is complicated bymajor haemorrhage, DAEmay identify and treat
the bleeding source beyond the reach of standard endoscopes.
The best route of approach during DAE may be determined by
prior SBCE [81]. Total enteroscopy rates using both oral and anal
approaches range from 20% to 80% [82,83]. In patients with es-
tablished Crohn’s disease, DAE (similarly to ileocolonoscopy)
may be particularly challenging because of adhesions angulating
the small bowel. Complications are discussed in detail in Section
7.2; the risk of complication has been reported to be higher in pa-
tients with active Crohn’s disease. In a recent report on the USA
experience, with 2254 DBE examinations to date, the complica-
tion rate was 10 times higher than that of colonoscopy [84]. Per-
forations were more common in patients with altered surgical
anatomy and two occurred during retrograde DBE in patients
with Crohn’s disease who had ulceration at the ileoanal or ileoco-
lonic anastomosis [84].
3.3.2 How does DAE compare with other imaging
modalities in patients with established Crohn’s disease?
Prospective, well-designed studies comparing DAE, SBCE, and
other imaging modalities in established Crohn’s disease are lack-
ing. The evidence available to date comes from unblinded case
series performed by expert endoscopists in specialist centres. Pa-
tients included in those series were heterogeneous both in terms
of indications for the procedure and the therapy performed
[11,49,79,80,85]. Ameta-analysis of 11 of these studies reported
that BAE (almost all were DBE) had a similar sensitivity to SBCE in
the diagnosis of small-intestinal inflammatory lesions [86]. Stud-
Statement 3D
" DAE is indicated when endoscopic visualization and
biopsies are necessary from areas of the small bowel
inaccessible to conventional endoscopy [EL5, RG C]
Statement 3E
" SBCE provides information on the optimal route
of approach (i. e., oral or rectal) by subsequent BAE
[EL3b, RG C]
Statement 3F
" In patients with established Crohn’s disease, adhesions
may limit examination by DAE, and, in these circumstan-
ces, DBE may be preferred to SBE [EL5, RG D]
" In a patient with stricturing active Crohn’s disease, there
appears to be a higher risk of complications [EL4, RG C]
Statement 3G
" DAE has the capacity for endoscopic therapy, including
dilation of Crohn’s disease small-bowel strictures, retriev-
ing foreign bodies, and treatment of bleeding lesions
[EL4, RG C]
Statement 3C
" For assessment of postoperative recurrence of Crohn’s
disease, SBCE should only be considered if ileocolonoscopy
is contraindicated or unsuccessful
" SBCE may identify lesions in the small bowel that have not
been detected by ileocolonoscopy after ileocolic resection
" SBCE has a potential role in the assessment of mucosal
healing after drug therapy [EL4, RG C]
Review 625
Bourreille A et al. Role of small-bowel endoscopy in IBD: international OMED–ECCO consensus… Endoscopy 2009; 41: 618–637
D
ow
nl
oa
de
d 
by
: U
ni
ve
rs
ità
 d
eg
li S
tu
di
 d
i M
ila
no
. C
op
yr
ig
ht
ed
 m
at
er
ia
l.
ies assessing the performance of SBE are only just emerging
[11,59,60,62,63,74] so no formal comparison with the other
techniques is possible.
SECTION 4
Inflammatory bowel disease-unclassified (IBDU)
!
4.1 Introduction
Population-based studies have demonstrated that in 4%–10% of
adult patients with all IBD affecting the colon, it is impossible to
distinguish between Crohn’s disease and ulcerative colitis using
current diagnostic techniques [87,88]. Establishing a definitive
diagnosis has implications in terms of medical and surgical ther-
apy, as well as clinical outcome.
The term ‘indeterminate colitis’, coined by Ashley Price in 1978
[89] to describe colectomy specimens that could not be confi-
dently classified as Crohn’s disease or ulcerative colitis, became
widely adopted to describe IBD any patient in whom it was im-
possible to reach a definitive diagnosis, whether or not the pa-
tient had undergone surgery [90]. This changed in 2006 when
an international working group [91] confirmed that the term ‘in-
determinate colitis’ would be reserved for those cases where co-
lectomy had been performed, but a definite diagnosis could not
be reached histologically. Colonic inflammatory bowel disease,
without small-bowel involvement, for whom a definite diagnosis
of either Crohn’s disease or ulcerative colitis could not be made
after ileocolonoscopy, biopsies, and small-bowel radiology would
be defined as colonic IBD, type unclassified (IBDU).
4.2 SBCE in patients with IBDU
4.2.1 Indications for SBCE in patients with IBDU
There is limited evidence for the role of SBCE in patients with
IBDU. The three full papers published [19,92,93] and eight ab-
stracts or letters [94–101] reporting the impact of capsule en-
doscopy (SBCE) on patients with IBDU are all retrospective and
involve small numbers of patients (each study has ≤ 31 patients).
SBCE demonstrates small-bowel lesions compatible with Crohn’s
disease in 17%–70% of patients with IBDU or indeterminate coli-
tis, but their clinical significance is unclear. Most studies used di-
agnostic criteria for small-bowel Crohn’s disease proposed by
Mow and colleagues (more than 3 ulcers seen on SBCE [19]).
These criteria, however, are both arbitrary and unvalidated (Sec-
tion 2.2.1). Conversely, a negative SBCE does not exclude a future
diagnosis of Crohn’s disease [102–104]. In one study [92], 5 of 25
patients with negative SBCE were eventually diagnosed with
Crohn’s disease at follow-up.
4.2.2 How does SBCE compare with other imaging
modalities in patients with suspected Crohn’s disease?
4.2.2.1 SBCE compared with SBFT/enteroclysis
Controlled trials in this patient group are lacking. Two out of
three published studies included patients who have had a nega-
tive SBFT [19,92].
4.2.2.2 SBCE compared with CTE
In patients with suspected or established Crohn’s disease, SBCE
revealed more inflammatory lesions in the proximal and mid-
small bowel when compared with CTE, but their clinical signifi-
cance is not known [21,43]. Currently there are no published
data comparing these two modalities in patients with IBDU.
4.2.2.3 SBCE compared with MR enteroclysis
Similarly there is no evidence to suggest which one of thesemod-
alities is superior in patients with IBDU. SBCE demonstrated
more inflammatory lesions in the small bowel compared with
MR enteroclysis, but their clinical significance is unclear [25].
4.3 DAE in patients with IBDU
4.3.1 Indications for DAE in patients with IBD-unclassified
(IBDU)
Evidence for the use of these techniques in patients with IBDU is
lacking. DAE allows direct mucosal inspection of the small bowel
and allows mucosal biopsy, which may facilitate diagnosis, but
this needs to be balanced against potential risks of the procedure.
4.3.2 How does DAE compare with other imaging
modalities in patients with IBDU?
There are currently no studies comparing DAE with radiographic
imaging modalities (SBFT, CT or MR enterography) in patients
with IBDU.
Statement 4C
" DAE includes promising diagnostic tools, but at the present
time there are no data supporting the use of these tech-
niques in patients with IBDU [EG5, RG D]
Statement 4B
" In patients with IBDU, SBCE is better than SBFT or entero-
clysis at identifying mucosal lesions consistent with
Crohn’s disease [EL3b, RG C]; in this subset of patients there
are no data comparing SBCE and either CTE or MR entero-
clysis
Statement 4A
" In patients with IBDU, SBCE can be helpful in identifying
those with mucosal lesions compatible with Crohn’s dis-
ease. A negative SBCE does not exclude a future diagnosis
of Crohn’s disease [EL3b, RG C]
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SECTION 5
Ulcerative colitis (including ileal pouch–anal
anastomosis [IPAA])
!
5.1 Introduction
Although ulcerative colitis is ultimately curable by colectomy,
many patients with the disease are managed medically for years
and undergo investigations to define the extent of the disease, as-
sess the severity of relapse, or identify complications. Differentia-
tion of Crohn’s disease from ulcerative colitis lies in being able to
show upper gastrointestinal tract or small-bowel involvement in
Crohn’s disease. This is occasionally necessary in patients with
established ulcerative colitis, when the diagnosis is questioned,
especially before surgery: indications and evidence for small-
bowel investigations in patients with ulcerative colitis and ileal
pouch–anal anastomosis (IPAA) are reviewed.
5.2 SBCE in patients with ulcerative colitis
5.2.1 Indications for SBCE in patients with ulcerative colitis
The diagnosis of ulcerative colitis is made using a combination of
medical history, clinical evaluation, and typical endoscopic ap-
pearances, confirmed by histopathology. Small-bowel radiology
is not routinely recommended [3], although some experts advise
small-bowel imaging to exclude Crohn’s disease prior to elective
colectomy for medically refractory ulcerative colitis.
Around 10% of patients with an initial diagnosis of ulcerative co-
litis will be reclassified as having either Crohn’s disease or IBDU
at follow-up. In one retrospective study [93], 19/120 (16%) pa-
tients had SBCE findings (defined as the presence of three or
more ulcerations [19]) consistent with Crohn’s disease. After ex-
cluding 8 patients with prior use of NSAIDs, the proportion of pa-
tients with small-bowel lesions was significantly lower in those
without a colectomy (12%) compared with those with a history
of colectomy (33%) (P = 0.04) [93].
Of 21 patients who had undergone colectomy for a presumed di-
agnosis of ulcerative colitis, 13 (62%) had documented pouchitis
on follow-up pouchoscopy, and six of those (46%) had SBCE find-
ings consistent with Crohn’s disease, defined as the presence of 3
or more ulcers. In a study [105] evaluating the utility of preopera-
tive SBCE in predicting long-term outcome of IPAA, 8 out of 20
patients with ulcerative colitis and IBDU had abnormal findings
on SBCE. Of these, only 1 (13%) presented with pouchitis at fol-
low-up compared with 4/12 (33%) patients who had a normal
preoperative SBCE. These data suggest that the presence of
small-bowel lesions prior to colectomy does not predict the post-
colectomy outcome.
In 17 ulcerative colitis patients with iron-deficiency anaemia
after IPAA, a combination of upper gastrointestinal endoscopy,
pouchoscopy with mucosal biopsy and histopathology, SBCE,
and coeliac disease serology, revealed a cause of anaemia in 5 (ar-
teriovenous malformation [AVM] in 1 patient, findings compati-
ble with Crohn’s disease in 3, and coeliac disease in 1) [106].
Anaemia after IPAA is therefore a reasonable indication for SBCE.
5.2.2 How does SBCE compare with other imaging
modalities in patients with ulcerative colitis?
5.2.2.1 SBCE compared with SBFT/enteroclysis
There is some evidence to suggest that the diagnostic yield of
SBCE is greater than that of SBFT/enteroclysis when an estab-
lished diagnosis of ulcerative colitis is questioned. In one study
[19], SBCE revealed lesions compatible with Crohn’s disease in
11/18 ulcerative colitis patients (including 6 with IPAA), 8 of
which were confirmed by histopathology. Of these, 5 had a nor-
mal SBFT previously. In 7 patients with an abnormal SBFT,
Crohn’s disease was confirmed in 4 patients. These results sug-
gest that information provided by SBCE may affect the evaluation
and management of patients thought or suspected to have ul-
cerative colitis, particularly those with negative conventional
small-bowel imaging.
In a retrospective study of 120 patients with a diagnosis of highly
suspected ulcerative colitis who underwent an SBCE [93], 19/120
patients had positive findings at SBCE and 18 of these (95%) had a
previously normal SBFT study, suggesting a higher diagnostic
yield of SBCE compared with SBFT. A proportion of ulcerative co-
litis patients with atypical symptoms (about 10%), medically re-
fractory disease (about 9%), or prior colectomy and new symp-
toms (about 33%) could be reclassified as having Crohn’s disease
if the diagnostic criterion of 3 or more ulcers at SBCEwas applied
[93]. Data on outcome after long-term follow up are lacking.
A case–control study [107] evaluated the use of SBCE for small-
bowel assessment in 16 patients with chronic refractory pouchi-
tis and 8 controls. SBCE demonstrated inflammatory changes in
all 16 patients with pouchitis compared with SBFT, which was
abnormal in only 2/16 patients. SBCE has a superior diagnostic
yield to SBFT, although the clinical significance of the small-bow-
el lesions detected is unclear.
5.2.2.2 SBCE compared with CTE
5.2.2.3 SBCE compared with MR enterography/
enteroclysis
There are no objective data comparing SBCE with CTE or MR en-
terography/enteroclysis in patients with ulcerative colitis. The
majority of the Consensus participants considered that data on
imaging techniques from patients with suspected or established
Crohn’s disease could be extrapolated to patients with ulcerative
colitis. The clinical significance of the small-bowel lesions detect-
ed is not certain.
Statement 5A
" The diagnosis of ulcerative colitis does not require SBCE
[EL5, RG D]
Statement 5B
" SBCE or DAE in a patient with a diagnosis of ulcerative co-
litis may be indicated if anaemia or abdominal symptoms
are unexplained despite conventional imaging [EL5, RG D]
Statement 5C
" SBCE can detect mucosal lesions in ulcerative colitis
patients with atypical or refractory symptoms, especially
after IPAA, but the clinical significance is unclear. The
presence of such lesions does not predict the outcome
after IPAA for ulcerative colitis [EL3b, RG C]
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5.3 DAE in patients with ulcerative colitis
5.3.1 Indications for DAE in patients with ulcerative colitis
There are currently no data regarding the use of DAE in patients
with ulcerative colitis, so no recommendations regarding indica-
tions for its use can be made.
5.3.2 How does DAE compare with other imaging
modalities in patients with ulcerative colitis?
Aswith IBDU (Section 4.3.2) the lack of data make it impossible to
make recommendations; however, the direct mucosal visualiza-
tion and biopsy capability of DAE could be seen as an advantage,
most probably when elucidating abnormalities identified by
other imaging techniques.
SECTION 6
Paediatric practice
!
6.1 Introduction
IBD starts at age <18 years in approximately 10%–15% of cases.
Among paediatric IBD cases seen in most areas of North America
and Europe, Crohn’s disease is far more common than ulcerative
colitis. The endoscopic assessment of the small bowel beyond the
ligament of Treitz and proximal to a short segment of the distal
ileum has been a major challenge for paediatric and adult gastro-
enterologists alike. Advances in SBCE and DAE, in addition to im-
proved imaging by CT and MR enterography, have improved the
ability to diagnose small-bowel pathology, but paediatric data re-
main limited.
6.2 SBCE in paediatric patients
6.2.1 Indications for SBCE in paediatric patients
US Food and Drug Administration (FDA) approval was granted in
2003 for SBCE use in children aged 10 years and over, on the basis
of the first controlled paediatric study [108] using the PillCam SB
capsule (Given Imaging Ltd, Yoqneam, Israel). The European So-
ciety of Gastrointestinal Endoscopy [109] and the American So-
ciety for Gastrointestinal Endoscopy [110] make no definitive
statement on the indications for SBCE in children, so current
practice refers largely to adult data and individual experience.
There are still few studies on the role of SBCE for the detection,
classification, or management of paediatric IBD.
Ten peer-reviewed paediatric studies published in English (case
series and comparative studies) have included 311 children with
a mean age of 12.8 years (minimum 16 months). SBCE was com-
pleted in 92% of procedures and significant clinical findings (de-
fined as a definite diagnosis, or change in diagnosis or clinical
management) were demonstrated by SBCE in 67%. The average
capsule excretion time (3 studies) was 42 hours, with a range of
6 hours to 30 days.
In the paediatric age group, the most commonly reported indica-
tion for SBCE was the investigation of suspected IBD (n = 145).
Other indications included obscure or occult gastrointestinal
bleeding with or without iron-deficiency anaemia (n = 66), her-
editary polyposis syndromes (n = 58), chronic abdominal pain
(n = 22), protein-losing enteropathy (n = 7), or growth failure
(n = 5). Other, less common indications included investigation of
idiopathic malabsorption or other undiagnosed enteropathies
[108,111–119]. SBCE can be considered in children with an es-
tablished diagnosis of Crohn’s disease who have unexplained
symptoms despite negative conventional endoscopy. In such
cases, a negative SBCE in combination with a normal ileocolono-
scopy would favour a diagnosis other than IBD to explain the
symptoms. Other potential indications for SBCE include assess-
ment of postoperative recurrence of Crohn’s disease and small-
bowel mucosal healing following medical therapy, but there is
no evidence from paediatric practice.
Suspected small-bowel Crohn’s disease is the main indication for
SBCE in the paediatric age group. In the first controlled prospec-
tive study [108], SBCE had a high diagnostic yield, with a diagno-
sis of Crohn’s disease or eosinophilic gastroenteropathy made by
SBCE in 60% of the 20 cases studied, compared with 0% using
conventional imaging techniques (SBFT and ileocolonoscopy). It
is again worth noting that the diagnosis of Crohn’s disease was
made using the criterion proposed by Mow et al. (3 or more ul-
cers in the small bowel [19]), which has not been validated, and
has uncertain clinical significance. A further study in adolescents
yielded similar results (58% vs 0%) for establishing a diagnosis of
Crohn’s disease missed by conventional imaging [117].
In up to 10% of adults with IBD involving only the colon, it is not
possible to distinguish Crohn’s disease from ulcerative colitis
(Section 4), but this increases to up to 30% in children [120]. In
the most recent study [112], 5 out of 7 children had their diagno-
sis changed from ulcerative colitis or IBDU to Crohn’s disease on
the basis of SBCE findings.
6.2.2 How does SBCE compare with other imaging
modalities in paediatric patients?
6.2.2.1 SBCE compared with SBFT/enteroclysis
SBFT and small-bowel enteroclysis have been the most common
diagnostic modalities used to investigate the small bowel in chil-
dren because of their accessibility, diagnostic value and cost-ef-
fectiveness [121–124]. However, a retrospective analysis of 164
children revealed a diagnostic sensitivity of only 45% (17/37) for
small-bowel radiography compared with ileocolonoscopy [125].
A major disadvantage of small-bowel radiography, especially in
children, is the radiation exposure, particularly if fluoroscopy
Statement 6A
" Gastroduodenoscopy with biopsies is necessary in all
paediatric patients suspected of having IBD [EL4, RG C]
Statement 6B
" SBCE can be helpful in identifying mucosal lesions
compatible with Crohn’s disease in paediatric patients
[EL3b, RG C]
Statement 6C
" SBCE should be performed in children or adolescents with
a high suspicion of Crohn’s disease, when conventional en-
doscopy and small-bowel imaging are normal [EL3b, RG C]
Statement 6D
" SBCE can be helpful in identifying mucosal lesions com-
patible with Crohn’s disease in paediatric patients with
ulcerative colitis or IBDU, although the clinical significance
of these lesions remains unclear [EL4, RG C]
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time is not kept to a minimum [126]. The mean relative effective
doses of radiation in children are: plain abdominal X-ray (AXR),
0.5 milliSievert (mSv); SBFT, 2mSv; and multidetector CT
(MDCT), 3.5 mSV.
There are few paediatric publications directly comparing SBCE
and SBFT/small-bowel enteroclysis. Most SBCE studies included
patients who had negative colonoscopies and SBFT [108,117].
Thomson et al. [114] showed that SBCE is more sensitive for
small-bowel pathology than SBFT (out of 19 children who had
abnormalities on SBCE, only 5 had abnormal results at SBFT) and
than upper intestinal endoscopy with ileocolonoscopy (only 10
had endoscopic findings compared with 23 at SBCE). Data from
paediatric case series suggests that SBCE is superior to SBFT/SBE
for detecting small-bowel pathology. Clinically relevant patholo-
gywas detected by SBCE, but not by SBFT/SBE in 10 of 20 children
in another study [115].
6.2.2.2 SBCE compared with CTE
CTE allows intra- and extraluminal assessment of the small bow-
el and colon but is associatedwith significant radiation exposure.
There are no paediatric studies comparing SBCE and CTE.
CTE has been compared with small-bowel contrast studies. In a
study of 18 children, a multidetector CTE was more acceptable
to patients than SBFT and yielded additional clinically relevant
findings [127]. White blood cell (WBC) scintigraphy and CTE
were compared with colonoscopy in a study where 99mTc-WBC
scintigraphy was more sensitive than CTE for detecting inflam-
mation of the bowel wall in children [128].
6.2.2.3 SBCE compared with MRE
Magnetic resonance imaging (MRI) also allows intra- and extra-
luminal assessment of the small bowel and colon, but without ra-
diation exposure. There are no studies comparing the diagnostic
value of SBCE with MRI in children with IBD.
Initial studies suggested MRI without contrast was insufficiently
reliable to investigate the small bowel in children with suspected
IBD [129]. However, the use of gadolinium and enteral contrast
solutions (e.g., polyethylene glycol [PEG], mannitol), resulted in
a high correlation with ileoscopy, histology and the Paediatric
Crohn’s Disease Activity Index (PCDAI) [130,131]. A sensitivity
of 96% and specificity of 92% was obtained with gadolinium-en-
hancedMRI for confirming an established histopathological diag-
nosis of either ulcerative colitis or Crohn’s disease in a study of 58
patients [132]. Studies in adults suggest the superiority of MR en-
teroclysis/enterography over conventional SB enteroclysis for de-
tection of mesenteric findings [133].
6.3 DAE in paedatric patients
6.3.1 Indications for DAE in paediatric patients
There are few data on the use of advanced enteroscopy (push en-
teroscopy, BAE, or DAE) in children.
Although push enteroscopy provides access to the small intestine
distal to the duodenum, its range is limited. Push enteroscopy
can, at best, reach 120–180 cm of small bowel beyond the liga-
ment of Treitz, although biopsy and therapeutic interventions
can be performed [134]. The yield, safety, and efficacy of push en-
teroscopy in 44 children has been reviewed [135]. Indications
were suspected small-bowel disease after radiological imaging
and/or gastrointestinal bleeding. Among 37 children with intes-
tinal pathology (not all IBD), lesions in only 9 were within reach
of a conventional endoscope. Enteroscopy led to amodification of
management in 34/44 patients. The procedure was not signifi-
cantly more time-consuming compared with upper endoscopy,
and no complications were reported.
There are no published studies on the use of DAE in childrenwith
IBD. DBEwas performed in 13 children for various indications in-
cluding occult gastrointestinal bleeding, iron-deficiency anaemia
and diarrhoea. The diagnostic yield was 86%, with nomajor com-
plications [136].
6.3.2 How does DAE compare with other imaging
modalities in paediatric patients?
There are no studies comparing DAE with SBCE, SBFT, CT or MR
enterography/enteroclysis in paediatric patients.
6.4 SBCE: safety and prior investigations
Available data suggest that SBCE is a useful diagnostic tool in the
paediatric age group. Certain considerations prior to the proce-
dure apply to both children and adults. Because of the nature
and length of the procedure, SBCE is not an emergency investiga-
tion. No tissue sampling is yet possible, and diagnoses based on
macroscopic appearances alone should be made with caution
[137]. NSAIDs commonly cause mucosal injury, including ulcera-
tions that mimic those seen in Crohn’s disease, but the use of
such anti-inflammatory drugs is far less common in children.
Histopathological confirmation of specific diagnoses suggested
by SBCE should be obtained, where feasible.
Small children require specific consideration and two factors
need to be considered – the ability to swallow the capsule and
the ability to pass the capsule. Limiting factors should be weight-
and not age-based. A capsule should pass the pylorus if a child
weighs more than 17 kg. In some cases, prior training with
sweets or candy may avoid the need for endoscopic insertion of
the capsule. In published studies, the majority of children swal-
lowed the wireless capsules voluntarily. Only 7% required endo-
scopic placement to the duodenum rather than the stomach, al-
though this may simply reflect recruitment bias in these initial
studies. Capsule retention is the most important adverse effect
and can occur in either the stomach or strictured small bowel
and require endoscopic or surgical removal. In 4%–5% of paedia-
tric cases, the capsule was retained in the stomach and required
endoscopic removal [115]. In a recent paediatric series [108], cap-
Statement 6E
" Advanced enteroscopic techniques (DAE) are promising
diagnostic tools, but at the present time there are no data
supporting the use of these techniques in paediatric pa-
tients with known or suspected IBD [EL5, RG D]
Statement 6F
" Although extensive data about the safety of SBCE in pae-
diatric patients are lacking, it seems to be a safe procedure
" In paediatric patients with established Crohn’s disease, it is
essential to attempt to exclude small-bowel strictures by a
thorough clinical history before SBCE. A patency (biode-
gradable, ‘dummy’) capsule should be used to reduce the
risk of retention, or MR enterography should be performed
if available
" There is no available evidence to support a particular bowel
preparation for children undergoing SBCE [EL5, RG D]
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sule retention occurred in 1/28 known cases of IBD. In the paedia-
tric literature there are reports of only three cases of capsule re-
tention in strictured small bowel that did not respond to corticos-
teroids and required surgical intervention [108,111,115]. Use of
a patency capsule can decrease the risk of capsule retention and
has been used in paediatric patients with good effect [64].
Visualization of the small bowel by SBCE may be impaired by
intestinal contents. Results from studies in adults that assessed
the value of bowel preparation are conflicting [138–140]. One
randomized, single-blind study in 90 adult patients showed best
mucosal visibility in patients who, prior to SBCE, had ingested 2 L
of PEG (72% visualization) compared with 1 L of PEG (52% visua-
lization), but either was superior to a clear liquid diet and over-
night fast (25% visualization) [138]. Although mucosal visualiza-
tionwas improved, it did not affect the diagnostic yield. There are
currently no data on the choice of bowel preparation in children.
Most paediatric studies use only an 8–12-hour overnight fast.
Bowel preparation can be traumatic for children and may require
nasogastric tube insertion.
SECTION 7
Complications and unresolved questions
!
7.1 Introduction
Unlike SBCE, which has been used for a decade, DAE is a relatively
newmodality and the true rate of adverse events is difficult to es-
tablish. This section addresses the complications of SBCE and DAE
reported in literature as well as their management. Key unre-
solved questions and areas for further research are discussed.
7.2 Complications
7.2.1 SBCE
Capsule retention in the small bowel is themost frequent compli-
cation, observed in 1.8%–5.8% of investigations in large series
where bleeding was the principal indication for the procedure
[141–145] (●" Table 3; bleeding was also the predominant indi-
cation in those series shown as having ‘Various’ indications). The
retention rate seems to be similarly low in patients with suspect-
ed Crohn’s disease (without symptoms or clinical findings sug-
gestive of intestinal obstruction), but can be up to 13% in patients
with an established diagnosis [22,44,141]. A capsule may be re-
tained despite a normal radiographic study [144,146]. In large
series including healthy volunteers taking NSAIDs for a short
period, no cases of retained capsule were documented [29–
31,147].
Clinical observation of patients with pacemakers or implantable
cardioversion devices undergoing PillCam SBCE [148] could not
demonstrate any relevant interaction. Neither simulation tests
with Given capsule systems held close to pacemakers [149] nor
in vitro experiments with Given and Olympus capsules [150]
showed important effects on pacemakers.
7.2.2 Push enteroscopy
Complications of push enteroscopy are more frequent than for
standard upper endoscopy. Complications include mucosal strip-
ping [151], perforation [152,153], and pharyngeal tear [154].
Such adverse events may have been related to use of an overtube
[155] during the procedure; these are no longer used for push en-
teroscopy in the majority of centres.
Table 3 Rates of retention in small-bowel capsule endoscopy (SBCE).
Indication Patients, n Retention, n (%)
Sears et al.
2004 [164]
Bleeding 52 3 (5.8)
Pennazio et al.
2004 [181]
Bleeding 100 5 (5)
Rondonotti et al.
2005 [144]
Various 733 14 (1.9)
Cheifetz et al.
2006 [142]
Various 568 19 (3.3)
Sturniolo et al.
2006 [145]
Various 304 4 (1.3)
Cheon et al.
2007 [143]
Various 1291 32 (2.5)
Sachdev et al.
2007 [73]
Various 115 3 (2.6)
Li et al.
2008 [182]
Various 1000 14 (1.4)
Statement 7E
" Diagnostic push enteroscopy has a low complication
rate that may be increased when an overtube is used
[EL3b, RG C]
Statement 7D
" There is no evidence that pacemakers or implantable car-
dioversion devices cause complications in patients under-
going SBCE, or vice versa [EL4, RG C]. Individual capsule
systems have to be tested for safety in this regard
[EL5, RG D]
Statement 7A
" In patients with suspected Crohn’s disease the risk of
small-bowel capsule retention is low and comparable to
that when the indication for SBCE is bleeding [EL3a, RG C]
Statement 7B
" In patients with an established diagnosis of Crohn’s
disease the risk of small-bowel capsule retention is in-
creased, particularly in those with known intestinal
stenosis [EL3b, RG C]
Statement 7C
" In patients with established Crohn’s disease of the small
bowel, it is essential to attempt to exclude small-bowel
strictures by a thorough clinical history and radiographic
imaging before SBCE. However, normal radiographic stud-
ies cannot entirely exclude the potential for small-bowel
capsule retention [EL4, RG C].
" A patency (biodegradable, ‘dummy’) capsule to reduce the
risk of retention should be considered, or DAE, if strictures
are identified
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7.2.3 Balloon-assisted enteroscopy (BAE)
With the development of DAE, intraoperative enteroscopy is per-
formed less frequently. Morbidity associated with intraoperative
enteroscopy has been reported in 3%–42% of cases, including
serosal tears (some requiring resection), avulsion of the superior
mesenteric vein, anastomotic leakage, abscess, or prolonged ileus
[156].
Diagnostic DBE is accompanied by complications in < 1% of cases.
Hyperamylasaemia has been documented in up to 50% of pa-
tients [157], but clinically significant pancreatitis occurs in only
1%, almost exclusively after use of the oral insertion route
[158,159]. Therapeutic balloon enteroscopy with balloon dila-
tion of strictures has a reported perforation risk of 0%–3%, which
is comparable to dilation of colonic Crohnʼs strictures [160,161].
Complications related to sedation during DBE led to termination
of the procedure in 11 of 3894 examinations [161]. Safety data on
SBE are still scarce, but may be comparable to those of DBE [11].
7.3 Management of complications
7.3.1 Capsule retention
Retained capsules in general do not cause obstruction and can re-
main intact for up to 4 years [19,144,146,162–164]. However,
single cases of acute obstruction have been reported [165]. In
one case, a fracture of a retained capsule was observed [166]
and one case of small-bowel perforation [167]. Removal of re-
tained capsule may require surgery, although removal by DBE
may be an option [77,168,169]. Use of a patency (biodegradable,
‘dummy’) capsule may help avoid capsule retention [66,170–
172], but rare adverse events including acute small-bowel ob-
struction have occurred with the device itself [64].
Only about a third of patients notice the passage of the SBCE, and
both capsule retention and small-bowel pathology may be over-
looked [173]. Visualization of the caecum seems to be a reliable
measure of excluding retained capsule, although long-term fol-
low-up is lacking.
7.4 What are the principal questions that remain
to be resolved?
7.4.1 Can Crohn’s disease be differentiated from other
pathologies on the basis of endoscopic findings?
Crohn’s disease, tuberculosis, cytomegalovirus infection, Behçet’s
disease, vasculitis, ischaemia and ingestion of NSAIDs are some of
the causes of ulcerating lesions in the small bowel. Their differen-
tiation appears impossible based on endoscopic images alone.
Within 2 weeks of taking NSAIDs, up to 75% of patients may
have small-bowel lesions [29,30]. Selective COX2-inhibitors
cause fewer small-bowel lesions [31].
7.4.2 Are there criteria that can be used to select patients
for SBCE?
Predictive markers for detection of small-bowel lesions sugges-
tive of Crohn’s disease have been described, although not valida-
ted in prospective studies. These include biochemical markers of
inflammation such as raised C-reactive protein (CRP) or erythro-
cyte sedimentation rate (ESR) [174], thrombocytosis [175], anae-
mia, faecal markers of inflammation (e.g., calprotectin, lactofer-
rin), and symptoms of abdominal pain, diarrhoea [176], or weight
loss [177]. Recurrent abdominal pain without other findings ex-
ceptionally rarely results in detection of clinically relevant lesions
in the small bowel [178,179], little different from colonoscopy for
isolated abdominal pain. This simply reflects the fact that endos-
copy (of any sort) examines themucosal lining and not thewall of
the intestine, wherein lie the enteric nerves. The long-term out-
come of patients found to have superficial small-bowel lesions is
currently not known.
Statement 7F
" Diagnostic DBE has a low complication rate, although
active Crohn’s disease or previous intestinal surgery may
increase the risk of perforation [EL3b, RG C]
Statement 7G
" DAE involves risk related to sedation, in contrast to SBCE
where no sedation is required [EL4, RG C]
Statement 7H
" Hydrostatic balloon dilation of short fibrotic strictures in
patients with small-bowel Crohn’s disease has a small, but
definable risk of perforation [EL4, RG C]
Statement 7I
" Passage of an intact patency capsule predicts safe transit of
a small-bowel capsule of identical or lesser size. A patency
capsule may itself cause obstruction at tight strictures, but
this is usually transient [EL4, RG C]
A retained small-bowel capsule can often be retrieved by
DAE [EL4, RG C]
Statement 7J
" Nonvisualization of the colon at SBCE should raise the sus-
picion of capsule retention. Follow-up until self-report of
capsule excretion or a plain abdominal radiograph after 2
weeks is advisable [EL5, RG D]
Statement 7K
" Endoscopic differentiation of small-bowel Crohn’s disease
from drug-induced lesions or other diseases is unreliable.
[EL3b, RG C] Findings have to be interpreted with the re-
sults of clinical symptoms, cross-sectional imaging, histo-
pathology, and biochemical markers [EL5, RG D]
Statement 7L
" Weight loss, anaemia, thrombocytosis, biochemical, or
faecal markers of inflammation, and serological markers
can be used to select patients for SBCE when Crohn’s dis-
ease is suspected and conventional endoscopy and radio-
graphic imaging are normal or inconclusive [EL3b, RG C]
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7.4.3 What scoring methods are appropriate for the
diagnosis and assessment of the severity of the disease?
There are currently no validated SBCE diagnostic criteria for
Crohn’s disease, ulcerative colitis or IBDU. Criteria proposed by
Mow et al [19] are arbitrary and not validated (see Section 2.2.1).
There are also no validated scores for either diagnosis or the as-
sessment of severity of small-bowel Crohn’s disease at SBCE or
DAE. Existing endoscopic scores for Crohn’s disease, such as the
CDEIS [32] or SES-Crohn’s disease [33], are only validated for ileo-
colonoscopy, or apply to the postoperative neoterminal ileum
(Rutgeerts’ score, [34]). SBCE scores that have been proposed are
based on the degree of villous oedema, mucosal ulceration, and
stenosis [35], or inflammation, extent of disease, and strictures
[36], but they have yet to be validated prospectively. Diagnostic
scoring needs to be validated in patients with suspected Crohn’s
disease and assessment scores in patients with established
Crohn’s disease.
7.4.4 What is the evidence behind new technology?
Spiral enteroscopy [16] could shorten the procedure time, as the
enteroscope is propelled through the small bowel using a rotat-
ing spiral, like an overtube. A single-use double-balloon spiral
overtube is available that can be mounted on most of the stand-
ard endoscopes, thus enabling push-and-pull manoeuvres [180].
Recent advances in endoscopic design include high definition
imaging and optical or electronic structure enhancement of ima-
ges, facilitating detection of subtle mucosal changes. Miniprobes
for endosonography and confocal laser microscopy can be used in
the small bowel, although their clinical value in the diagnosis of
Crohn’s disease has not yet been established. Endoscopic ultra-
sound has the potential to provide information on bowel wall
thickness and thereby evaluate the true transmural inflamma-
tory process.
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Statement 7M
" Prospective studies are required to define diagnostic crite-
ria by SBCE for Crohn’s disease [EL5, RG D]
Statement 7O
" Improved visualization of the mucosa is achieved with
high-resolution and magnification endoscopy. Small-bow-
el spectral light selection, endoscopic ultrasound, and con-
focal laser microscopy via miniprobes have yet to prove
their value in clinical practice. Modified procedures such as
spiral or balloon-guided enteroscopy have to be evaluated
in comparison with established techniques [EL5, RG D]
Statement 7N
" Scores for diagnosis and for assessing the activity or sever-
ity of Crohn’s disease by SBCE or DAE are desirable and
should be validated prospectively [EL5, RG D]
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